5-fluorotryptamine monohydrochloride has been researched along with methazolamide in 1 studies
| Studies (5-fluorotryptamine monohydrochloride) | Trials (5-fluorotryptamine monohydrochloride) | Recent Studies (post-2010) (5-fluorotryptamine monohydrochloride) | Studies (methazolamide) | Trials (methazolamide) | Recent Studies (post-2010) (methazolamide) |
|---|---|---|---|---|---|
| 6 | 0 | 2 | 456 | 23 | 114 |
| Protein | Taxonomy | 5-fluorotryptamine monohydrochloride (IC50) | methazolamide (IC50) |
|---|---|---|---|
| Carbonic anhydrase 12 | Homo sapiens (human) | 0.02 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.014 | |
| Carbonic anhydrase 1 | Homo sapiens (human) | 0.0469 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.0347 | |
| Carbonic anhydrase 3 | Homo sapiens (human) | 0.02 | |
| Cathepsin B | Bos taurus (cattle) | 0.02 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.014 | |
| Carbonic anhydrase 4 | Homo sapiens (human) | 0.0792 | |
| Carbonic anhydrase 6 | Homo sapiens (human) | 0.02 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.014 | |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | 0.02 | |
| Carbonic anhydrase 7 | Homo sapiens (human) | 0.02 | |
| Carbonic anhydrase 9 | Homo sapiens (human) | 0.0158 | |
| Carbonic anhydrase 13 | Homo sapiens (human) | 0.02 | |
| Carbonic anhydrase 4 | Bos taurus (cattle) | 0.036 | |
| Carbonic anhydrase 14 | Homo sapiens (human) | 0.02 | |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for 5-fluorotryptamine monohydrochloride and methazolamide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |